Thank you for standing by, and welcome to the OSI Systems First Quarter 2024 Conference Call. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Alan Edrick, Chief Financial Officer. Please go ahead, sir.

Good morning, and thank you for joining us. I'm Alan Edrick, Executive Vice President and CFO of OSI Systems, and I'm here today with Deepak Chopra, OSI's President and CEO. Welcome to the OSI Systems Fiscal 2024 First Quarter Conference Call. We are pleased that you can join us as we review our financial and operational results. Earlier today, we issued a press release announcing our 2024 fiscal year first quarter financial results. Before we discuss our results, however, I'd like to remind everyone that today's discussion will include forward-looking statements, and the company wishes to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 with respect to such forward-looking statements. All forward-looking statements made on this call are based on currently available information, and the company undertakes no obligation to update any forward-looking statement based on subsequent events or new information or otherwise. During today's call, we will refer both to GAAP and non-GAAP financial measures when describing the company's results. For further information regarding non-GAAP measures and comparable GAAP measures of the company's results and a quantitative reconciliation of those figures, please refer to today's earnings release. I will begin with a high-level summary of our financial performance for the first quarter of fiscal '24 and then turn the call over to Deepak for a discussion of our business and operational performance. We will then finish with more detail regarding our financial results and a discussion of our outlook for fiscal year '24. Our first quarter financial results were generally solid, with the Security Division again generating double-digit revenue growth and significant year-over-year operating margin expansion, and the Opto division performing very well, while the Healthcare division experienced a challenging quarter. We are enthusiastic about the overall significant revenue and earnings growth anticipated for the balance of fiscal '24. Let's start with a high-level summary of our Q1 results. First, we reported Q1 revenues of $279 million, representing a year-over-year increase of 4%, driven by revenue growth of 14% in our Security Division and 2% in the Opto Division, which were partially offset by a 13% decrease in revenue in the Healthcare division. Second, we reported Q1 non-GAAP adjusted earnings per share of $0.91, up 5% from Q1 of the prior fiscal year, as strong operating results overcame the impact of approximately $0.11 per share of additional interest expense associated with higher interest rates in our borrowings. Third, we ended the quarter with a backlog of nearly $1.8 billion. The strong backlog provides outstanding visibility for the full fiscal year. Before diving more deeply into our financial results and discussing the fiscal 2024 outlook, I will turn the call over to Deepak.

Thank you very much, Alan. Good morning to everyone. I'm pleased to report that our fiscal 2024 first quarter performance aligned with our expectations. We achieved 4% revenue growth with increased margins. With a strong backlog, coupled with significant recent awards and high visibility into the opportunity pipeline, we expect significant revenue and adjusted earnings per share growth through fiscal '24 and beyond. So let's dive into the performance and highlights of each division during the quarter and begin with the Security Division, which saw an increase of 14% in Q1 revenues and operating margin expansion. The division had bookings of 174 million during the quarter, resulting in a book-to-bill ratio of 1.1. During the quarter, we made considerable progress on the ramp-ups for our recently awarded port and border security initiatives with Mexico's Defense Agency SEDENA and other international customers. We anticipate that both programs will contribute substantial revenues in this fiscal year. During Q1, we successfully captured several port and border security customer opportunities in the U.S. and internationally. On the international front, we announced an award for $14 million from a Latin America-based customer to provide multiple units of our Eagle P60 high-energy drive-through cargo and vehicle inspection system. Also, the VM250 radiation portal monitors and the MINI Z handheld backscatter devices, along with our proprietary CertScan integration installation software and training and maintenance service and support. In addition, we also announced a $10 million contract from an international customs agency to provide a dual energy X-ray cargo and vehicle inspection solution, including multiyear maintenance service and support. In the U.S., we announced a $14 million award from an existing U.S. customer to provide civil works and installation support for our cargo and vehicle inspection systems. And wrapping it up in the ports and borders shortly after the quarter end, we announced an award that we received in Q1 of a 10-year contract to provide a turnkey screening solution to Uruguay's Ministry of Economics and Finance. The Eagle P60 high-energy, trailer-mounted vehicle inspection system will be used to perform security screening and remote image analysis utilizing the proprietary CertScan integration platform. We will also provide on-site operator training, ongoing maintenance, service and support. I just want to talk a little bit more about our CertScan software, which is our proprietary software solution that helps manage inspection image data, traffic, and vehicle identification at checkpoints. Along with CertScan's utilization as a critical piece in a turnkey solution, we utilize CertScan frequently on traditional hardware installations as customers increasingly integrate screening systems with existing data and communication centers. Furthermore, when new data managed infrastructure is required for specific program initiatives, we are often involved in supporting the planning and construction of these facilities. The Uruguay program will join our long-standing successful turnkey projects like Puerto Rico, Albania, etc., where we have demonstrated our experience and capabilities in handling large-scale programs for customs and border protection agencies. We have an extensive presence with the U.S. Customs and Border Protection, CBP, in the United States where we are actively supporting recent border security efforts through equipment and service orders received to date for about $200 million. The CBP has room under two active indefinite delivery, indefinite quantity contracts that have a combined total potential award value of about $870 million. Although the U.S. government is currently operating under a continuing resolution, we are hopeful that additional orders could be issued once the U.S. government's '24 budget is passed and signed into law. Our checkpoint security products and related services team continues to support its customer base in airports, transportation, government facilities, and other critical infrastructures. Our latest explosive trace detection system, ETD, the Itemiser 5X, is now approved by the European Union for use at European airports qualified by TSA, ACSTL for air cargo, and certified by the China Aviation Authority for use at airports. The Itemiser 5X has some of the most advanced software algorithms and optimized detection capabilities, making it an ideal tool for identifying explosives, narcotics, and other harmful compounds. We have been diligently collaborating with international airports regarding potential passenger and baggage screening enhancements to align with the latest technology regulatory standards. We remain optimistic about the continued expansion in the aviation CT checkpoint and checked baggage area, together with the Itemiser 5X projects and have a good healthy backlog. Overall, the Security division had a great start for fiscal '24. And with a strong backlog, we expect it will do significantly better in the remainder of fiscal '24. Moving to the Optoelectronics and Manufacturing division. Opto delivered impressive results during the first quarter with another all-time quarterly revenue record, achieving $96 million in revenue, including intercompany, and generating strong profitability. In addition to being a vital supplier to our Security and Healthcare divisions, Opto continues to serve its diverse OEM customer base that provides various solutions in aerospace, defense electronics, test and measurement, medical devices, automotive, and consumer electronics. With our strong global presence manufacturing covering the U.S., England, India, Indonesia, and Malaysia, combined with a continued trend of customers seeking robust manufacturing alternatives to China, we look forward to capturing new opportunities with our existing customer base and new customers. Finally, on to the Healthcare division, where Q1 was a tough quarter as sales went down 13% year-over-year due to challenging market conditions, especially in the U.S., where hospital profitability has been hampered, which, in turn, has caused delays in capital expenditures. The silver lining was growth in the European region, backed by a recently launched cardiology product and services. The capital constraints at hospitals are actually helping to drive market adoption of a new business model that we discussed before, which reduces the need for significant capital outlays. This division continues to develop innovative new business models and solutions such as leasing and subscription programs. The Rothman Index-based predictive analytics software and SafeNSound patient alarm management software are good examples of tools that can help hospitals increase the efficiency of their existing patient monitoring infrastructure. We continue to invest significantly in R&D and new product innovations. Although Healthcare didn't start well in the first quarter, we expect its performance to improve during the rest of the year '24. In summary, with significant backlog in security and Opto, we are confident about our prospects in these divisions. We also expect more robust performance from Healthcare as we look forward to the rest of fiscal '24. With that, I'll turn the call back over to Alan Edrick to talk in more detail about our financial performance before opening the call for questions. Thank you.

Well, thank you, Deepak. Now I will review in greater detail the financial results for our fiscal '24 first quarter. Again, our Q1 revenues were up 4% compared with that of the first quarter in the prior fiscal year. Q1 Security Division revenues were up 14%, largely due to the growth in our cargo and vehicle inspection products and related service revenue. This included modest shipments from the $200 million plus cargo contract announced in January. Aviation-related revenues increased as well. The book-to-bill ratio in the Security Division for Q1 was 1.1, leading to a record backlog in this division. Opto sales increased 2% year-over-year, driven primarily by strong intercompany sales to support anticipated Security Division growth, which was partially offset by reduced third-party revenues as certain Opto customers are rightsizing inventory levels or had programs delayed. The Healthcare division, as Deepak mentioned, had a challenging first quarter with year-over-year revenues down 13%, driven primarily by reduced patient monitoring product sales. The fiscal '24 Q1 gross margin of 35.4% was up significantly over the 32.6% gross margin in Q1 last year, despite the reduction in sales in Healthcare, which is the division with the highest gross margin among our three divisions. The gross margin expansion was led by the Security Division, which experienced a favorable mix of sales, along with the execution of certain operational improvements. Our gross margin will generally fluctuate from period to period based on revenue mix and volume, inflation, and impacts of changes in supply chain costs, among other factors. Moving to operating expenses. We continue to work diligently across each of our divisions to improve efficiency and to prudently manage our SG&A cost structure. Q1 SG&A expenses were $59.8 million, representing a 12% increase over the prior year, driven by less favorable FX and a lower level of bad debt recoveries in Q1 of fiscal '24 compared to the prior year. We do expect to leverage our SG&A for the full year of fiscal '24, where such expenses are expected to decline as a percentage of sales on an annual basis. Research and development expenses in Q1 of fiscal '24 were $15.9 million, up from $14.5 million in the same prior year quarter. We continue to dedicate considerable resources to R&D, particularly in Security and Healthcare, as we remain focused on innovative product development, which we view as vital to the long-term success of our businesses. In Q1 of fiscal '24, we recorded $0.5 million of impairment restructuring and other charges compared to $1.2 million of such charges in the comparable quarter of the prior fiscal year. Moving to interest and taxes. Net interest and other expenses in Q1 increased from $3.4 million in fiscal '23 to $5.7 million in fiscal '24, primarily due to increased interest rates in our borrowings. We executed an interest rate swap during Q1 of fiscal '23 to fix a portion of our floating rate bank debt. On the tax side, the reported effective tax rate under GAAP was 23.4% in Q1 of fiscal '24 compared to 24.4% in Q1 of fiscal '23. In Q1 of this year, we recognized a discrete tax benefit of $0.4 million compared to $0.1 million in Q1 of the last fiscal year. Excluding the impact of discrete tax items, our normalized effective tax rate in Q1 of fiscal '24 was 25.8% compared to a normalized effective tax rate of 25.1% in Q1 of fiscal '23. I will now turn to a discussion of our non-GAAP adjusted operating margin. Overall, our non-GAAP adjusted operating margin in the first quarter of fiscal '24 increased to 9.6% from 8.7% in Q1 of fiscal '23, driven by strength in the Security and Opto Divisions. The non-GAAP adjusted operating margin in the Security Division expanded to 14.3% in Q1 of this year from 12.8% in Q1 of last year, primarily due to the mix of sales and operational improvements. The operating margin in our Opto Division was again solid, increasing to 12.8% in the first quarter of fiscal '24 from 12.7% in last year's Q1. And with the reduction in sales in the Healthcare division, this segment's adjusted operating margin was negligible. Moving to cash flow. Cash provided by operations was $17 million in Q1 of fiscal '24, which was comparable to the prior year first quarter, despite the significant build of inventory that we mentioned on the last earnings call would occur in preparation for program deliveries under the two large Security Division contracts announced in fiscal '23. CapEx in the 2024 fiscal first quarter was $5.2 million, while depreciation and amortization in Q1 was $9.6 million. Our balance sheet is solid, with modest net leverage of under 1.4 and significant capacity for investments, acquisitions, and stock buybacks. Aside from $7.5 million of annual required principal repayments under our bank term loan, the bulk of our debt matures in fiscal '27. And finally, turning to guidance. We are reiterating our fiscal '24 revenues, and we are increasing our non-GAAP diluted EPS guidance. We continue to expect our fiscal '24 revenues to increase more than 18% over revenues in fiscal '23. We expect our fiscal '24 non-GAAP diluted EPS to grow more than 27% over our non-GAAP diluted EPS in fiscal '23. This fiscal '24 non-GAAP diluted EPS guidance excludes potential impairment, restructuring, and other charges, amortization of acquired intangible assets and noncash interest expense and their associated tax effects as well as discrete tax and other nonrecurring items. We currently believe this guidance reflects reasonable estimates. The actual impact on the company's financial results of timing changes on expected revenues, disruptions and increased costs in the supply chain, and inflation and interest rates is difficult to predict and could vary significantly from the anticipated impact currently reflected in our estimates and guidance. Actual revenues and non-GAAP earnings per diluted share could also vary from the guidance anticipated above due to other risks and uncertainties discussed in our SEC filings. We continue to remain focused on the growth of our businesses and proactive management of our cost structure. We believe our efforts will enable OSI to continue providing innovative products and solutions. We would like to take this opportunity to thank the global OSI Systems team for its continued dedication in supporting our customers and partners. And at this time, we would like to open the call to questions.

Our first question comes from Josh Nichols from B. Riley.

And it's really good to see the company with a new turnkey Security award here in Uruguay. A couple of questions there. These have been historically high-margin awards for the company. One, how long do you expect for this to ramp up and any context you could give us in terms of the potential size of the award?

This is Deepak here. This is not a very large contract, and it will take us about 6 to 8 months to get it going. And basically, it’s similar in size to the other contracts that we have. And we're very excited about it because one of the things that we are very proud of when we get these kinds of turnkey contracts in different areas, they become like a centerpiece for the rest of the area to look at it. All these turnkey contracts help the trade between Uruguay and, for example, North America or Europe. So we continue to look at these big successes moving forward. Alan, do you want to add something to it?

No. I think that was good. And Josh, while we don't talk about margins on specific deals, generally speaking, the margins on our turnkey contracts are significantly above our overall corporate average.

Well, thanks for confirming that the company has really been building out its Security portfolio. You've been granted approval for ETD with the TSA now to, how should we think about the timing and opportunities specifically for ETD over the next 12 to 18 months and how that could ramp up?

Again, we are very proud of the certification. We think it's a great product. We do definitely know that in air cargo, there's a significant revamp going on for new technology. And we are very well poised for it. In the international sector, we think that the growth will come even faster. So we are very excited about it. As we go back and look at the performance of these units compared to the existing products, we believe that we'll continue to see a lot of success.

And our next question comes from the line of Jeff Martin from ROTH Capital Partners.

I wanted to understand the timing of the two large orders that will be significantly increasing soon. How much has your visibility on the timing changed since the Q4 call? Additionally, can you provide an update on whether you have been able to source the necessary components? I know you are ordering much more than usual, so any insights on both timelines and your experiences would be appreciated.

Jeff, this is Alan. I'll take the first part of that question. Our visibility continues to improve as we go month by month on these 2 large contracts. There are, as you would imagine, often evolving changes with large contracts, but we're really excited about it. We do anticipate starting to see a real ramp-up in revenues on these contracts beginning now in this quarter, Q2, which is really going to generate some significant revenue growth, we believe, over the balance of fiscal '24. So we expect that there will always be some changes to the timing and the schedule. That's the nature of the business in this industry, but the visibility continues to improve, and the ramp-up is happening as we speak.

Just to add to that, this is Deepak here. Basically, on the supply chain issue, we are handling it well. And as I stated in the last conference call, we are well positioned compared to our competitors because we have intercompany resources. We cannot ignore the fact that when you ramp up significantly so fast, there are definitely challenges in the supply chain. We are addressing it. And as Alan has mentioned, we will start seeing significant growth from both of these contracts in Q2, moving into Q3 and Q4.

Great. And then my other question is with the unrest in the Middle East, does that create potential opportunities for you? Are you seeing increased inquiries from countries and the surrounding areas for stepping up their port and border equipment inspection capabilities or other areas?

Well, first, I would like to say that we are very saddened by what's happened there. We continue to pray for everybody's well-being. I haven't seen any changes regarding the situation in the Middle East because, obviously, this is something recent. However, on the Ukraine project and similar situations, definitely as conditions mature in that area, it's logical to assume that countries around that area will need more security equipment, and we continue to explore those opportunities. We're working on it. At the same time, funding is very important. As you know, the U.S. has been in a tough situation with what's happening in Washington. Once that opens up regarding both the Middle East challenges and the Ukraine-Russia challenges, we are positioned well for any equipment procurement.

And our next question comes from the line of Larry Solow from CJS Securities.

Just, I guess, a follow-up to the last question just on how the contracts are ramping. And just specifically, Alan, just in terms of the increase in guidance, I know you don't guide, but to the sectors or the segments. But, I guess, it’s sort of the increase I feel like is that coming from Security? Is that just increased confidence there? Or what typically drives you to increase your EPS outlook this year?

Yes. Great question, Larry. Your hunch is correct. The growth in the EPS guidance is coming from our Security business. You saw in our Q1 that we just reported, we saw some nice operating margin expansion, which led to stronger earnings. As we look out through the balance of the year and some strength in that business, that is really what has driven us to increase the overall EPS guidance. We expect Opto to continue to perform well in addition to that, but Security is leading that growth in the EPS guidance.

I'm not sure if you provided the book-to-bill ratio for Security, but if you have that information, it would be helpful. Additionally, given that the world isn't becoming a safer place, how are the opportunities in your product offerings and sales pipeline trending, both within vehicle inspection and in other areas? Also, if you could share the book-to-bill ratio for the quarter, that would be appreciated.

Yes. So Larry, this is Alan. The book-to-bill in security was 1.1, positioning us in a record backlog: the highest backlog of all time for our Security Division. The visibility is strong. The funnel of opportunities is robust worldwide due to the nature of our product lines. Maybe Deepak, do you want to add to that?

Yes. I just want to emphasize that the opportunities are growing, both in the border area, air cargo, and also in the aviation sector. That had been largely on hold during the COVID time. But as it resumes, the traffic is increasing, and there is a lot of interest in upgrading to new technology products both in the Itemiser and the RTT checkpoint and checked baggage area. We continue to look at it, and we are very optimistic about the funnel.

Okay. Lastly, I want to switch topics to Healthcare. It seems to have had a slower start this year than anticipated. I have two questions. If you could share your thoughts, do you still believe that the segment can achieve growth in both revenue and operating profit over the full year?

Well, good question. Good analysis you've done. On the equipment side, definitely, we were disappointed, especially in the U.S. with the equipment sale. There are two other things to address. One is, we continue to invest in R&D to develop a new platform of patient monitoring. At the same time, this new model that is in its infancy, we have started, which is subscription and software model, is attracting quite a bit of interest. Although this is a new approach, it remains in infancy. Interestingly, we've been doing this on the Security side, so now applying it to Healthcare, we know the building blocks. The question is how to educate customers and prove to them the value. We are quite excited about this new model of ongoing revenue, which resembles the turnkey model we have on the Security side. Alan, do you want to add something?

Sure. To your questions, Larry, yes, these new models are in their infancy, and we think they're going to grow nicely over the coming years. Our expectation is that the Healthcare division will grow for the full fiscal year in '24, both on the top line and the bottom line.

Our next question comes from Christopher Glynn from Oppenheimer.

A lot has been asked. One follow-up. I think you said you expect on Healthcare, some nice improvement starting sequentially really for the balance of the year relative to the first quarter. It sounds like you were caught off guard a little bit in the first quarter after some fourth-quarter strength. So wondering how you would describe the visibility to the expected pickup there?

Well, yes, we are disappointed in the first quarter. However, keep in mind that over the years, firstly, it's a single-digit growth area, and it's booked and shipped, not driven by backlog. Some orders came in Q4, and we were expecting some in Q1, but they didn’t materialize, so that is a bit disappointing. However, the team feels very focused that the remainder of the year will improve. The innovations we are doing in both SaaS models and the development of new product portfolios won't have a significant impact in 2024. Our current focus is on capturing the accounts we have and working with hospitals to enhance their efficiency.

No, I think that describes it well.

Okay. And it was nice to see positive free cash flow in the first quarter. It's often a challenging seasonal quarter and in particular, this year, just ahead of significant ramps at Security. So wondering if you could give some color on what sort of levels, range, metrics around free cash flow we should be looking for this year?

Chris, this is Alan. Good question. While we don't provide free cash flow guidance, we would agree with your statement in light of growing our inventory by $80 million to support the large Security contracts, generating $17 million or so of operating cash flow was quite strong in Q1. As we look out, there will be some continued buildup in inventory for these contracts. We think that where our significant free cash flow could be driven is in fiscal '25, fiscal '26, and beyond. Historically, we've been a very strong generator of free cash flow, and we believe that strength will only increase as we move beyond this fiscal year. We do expect to generate nice free cash flow this year, but the real strength will begin in the subsequent fiscal year.

Okay. And then just one on Opto and manufacturing, really looking very sturdy, a lot of short-cycle volatility out there from OEMs and distribution impacting a lot of names. I’m curious if you could describe a little bit about what's providing that stability, particularly how externals performed? And if you're seeing a regular cadence of wallet share additions with your global customers as they try to derisk supply chains?

Well, again, a great question. It’s a different marketplace. In some cases, there is a very predictable customer base. We work with OEMs and continue to look at it. They are also going through inventory increases, and it’s a continuing evolving matter. The thing that gives us a significant advantage compared to our competitors is our broad customer base across aerospace, defense, automotive, medical, consumer, etc. Some sectors are weak, while others are strong. We keep emphasizing our global manufacturing presence as a key advantage. There's a lot of discussions about alternatives to China manufacturing, and we can produce products from our locations in Asia, the U.S., and Europe for our customers. We see this business as well thought out and predictable, but there’s also a careful focus needed depending on our customer base.

No, I think that sums it up well.

This does conclude the question-and-answer session of today's program. I'd like to hand the program back to management for any further remarks.

Well, thank you very much, and we again want to thank all the employees of the company and all the customers and everybody else, including the stockholders and not to forget the analysts. We are very excited about the rest of the year. The backlog is strong to support it, and we are looking at a lot of other opportunities. We believe that the remainder of the year starting in Q2 into Q3 and Q4 will be very strong. Thank you very much. Talk to you in January.

Thank you, ladies and gentlemen, for your participation in today's conference. This does conclude the program. You may now disconnect. Good day.